Zobrazeno 1 - 10
of 41
pro vyhledávání: '"van Bodegraven, A. A."'
Autor:
Jan van den Brande, Tessa Uiterwaal, Christianne J. Buskens, Juda Vecht, Robert E G J M Pierik, Job H.C. Peters, Nofel Mahmmod, John Maring, E. Joline de Groof, Toer W. Stevens, H. B. A. C. Stockmann, Pieter C. F. Stokkers, Karlien F. Bruin, Eric J. Hazebroek, Ailsa Hart, Arnold van de Laar, Hubert A Prins, Richard van Hillegersberg, Rachel L. West, Paul Kingma, Menno A. Brink, Pritesh Morar, Ruud Schouten, Marno C.M. Rijk, A Jeroen de Groof, Sijbrand Hofker, Annekatrien Depla, Bregje Mol, Janneke van der Woude, T. J. Gardenbroek, Janindra Warusavitarne, Bas Oldenburg, Edwin S. van der Zaag, Anna A. W. van Geloven, Rogier M P H Crolla, Emma J. Eshuis, Hans Brouwer, Meindert N. Sosef, Maria L Haasnoot, Geert R. D'Haens, Nynke Talstra, Marcel Spanier, Liekele Oostenbrug, Jeroen M. Jansen, Maarten J Boom, Donald L. van der Peet, Nanne K. H. de Boer, Willem A. Bemelman, Cyriel Y. Ponsioen, Rosalie C Mallant, Theo J.M. van Ditzhuijsen, Gerard Dijkstra, Alexander P.J. Houdijk, Willem A. Marsman, Djuna Cahen, Casper G. Noomen, Huib A. Cense, Esther C. J. Consten, Michael F. Gerhards, Ad A. van Bodegraven, Rob J. Lieverse, Andreas Marinelli, Sjoerd van der Werff, Clemens Bolwerk, Ernst Jan Spillenaar Bilgen, Quirijn A. J. Eijsbouts, Guido Mannaerts, Bart A. van Wagensveld
Publikováno v:
The lancet. Gastroenterology & hepatology, 5(10), 900-907. HANLEY & BELFUS-ELSEVIER INC
LIR!C study group 2020, ' Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn's disease : retrospective long-term follow-up of the LIR!C trial ', The Lancet Gastroenterology and Hepatology, vol. 5, no. 10, pp. 900-907 . https://doi.org/10.1016/S2468-1253(20)30117-5
The Lancet Gastroenterology and Hepatology, 5(10), 900-907. Elsevier Ltd
lancet. Gastroenterology & hepatology, 5(10), 900-907. Elsevier Limited
LIR!C study group 2020, ' Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn's disease : retrospective long-term follow-up of the LIR!C trial ', The Lancet Gastroenterology and Hepatology, vol. 5, no. 10, pp. 900-907 . https://doi.org/10.1016/S2468-1253(20)30117-5
The Lancet Gastroenterology and Hepatology, 5(10), 900-907. Elsevier Ltd
lancet. Gastroenterology & hepatology, 5(10), 900-907. Elsevier Limited
BACKGROUND: The LIR!C trial showed that laparoscopic ileocaecal resection is a cost-effective treatment that has similar quality-of-life outcomes to treatment with infliximab, an anti-tumour necrosis factor (TNF) drug. We aimed to compare long-term o
Autor:
Marie J. Pierik, Tamara Munnecom, Paul J. Boekema, Daisy Jonkers, Mariëlle Romberg-Camps, Ad A. van Bodegraven, Laura Janssen, Manuela A. Joore, Michèl Aquarius, Lloyd Brandts, Jeoffrey J L Haans, Adrian A. M. Masclee
Publikováno v:
BMJ Open, 11(5):042885. BMJ Publishing Group
BMJ Open, Vol 11, Iss 5 (2021)
BMJ Open
BMJ Open, Vol 11, Iss 5 (2021)
BMJ Open
IntroductionCrohn’s disease (CD) is a chronic inflammatory bowel disease with a heterogeneous clinical presentation, relapse rate and treatment response. At present, no markers are available to adequately predict disease course at diagnosis. To pre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::082cad4540ff81c812c4b0ebca66caee
https://cris.maastrichtuniversity.nl/en/publications/81594221-89e3-447d-8ffe-d421ae541a5a
https://cris.maastrichtuniversity.nl/en/publications/81594221-89e3-447d-8ffe-d421ae541a5a
Autor:
Bjorn Winkens, Jeoffrey J L Haans, Andrea E. van der Meulen-de Jong, Daisy Jonkers, Ad A.M. Masclee, Nofel Mahmmod, Dion S J Wintjens, Marco C. Becx, Tineke Markus, Ad A. van Bodegraven, Marie J. Pierik, Mariëlle Romberg-Camps, Marin J de Jong, Jeroen Maljaars
Publikováno v:
Journal of Crohn's & Colitis, 13(4), 410-416. Oxford University Press
Journal of Crohn's and Colitis, 13(4), 410-416
Journal of Crohn's and Colitis, 13(4), 410-416
Background and Aims Inflammatory bowel disease [IBD] is characterized by recurrent disease flares. The impact of psychosocial wellbeing on the occurrence of flares is unclear. In this prospective study, we aimed to evaluate the association between pa
Autor:
Matthieu Allez, Silvio Danese, Severine Vermeire, Ailsa Hart, Stephan R. Vavricka, Javier P. Gisbert, Stefan Schreiber, Ad A. van Bodegraven, Fernando Magro, Laurent Peyrin-Biroulet, Jonas Halfvarson, Peter L. Lakatos, Iris Dotan, Dino Tarabar
Background: The authors aimed to conduct an extensive literature review and consensus meeting to identify unmet needs in ulcerative colitis (UC) and ways to overcome them. UC is a relapsing and remitting inflammatory bowel disease with varied, and ch
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2907ad2f555b50d65943c2199e979e98
Publikováno v:
van Bodegraven, A A, Mulder, C J J & Bravenboer, N 2020, Osteoporosis associated with gastrointestinal disorders : Celiac and inflammatory bowel diseases . in Marcus and Feldman’s Osteoporosis . Marcus and Feldman’s Osteoporosis, Elsevier, pp. 1069-1082 . https://doi.org/10.1016/B978-0-12-813073-5.00043-5
Marcus and Feldman’s Osteoporosis, 1069-1082
STARTPAGE=1069;ENDPAGE=1082;TITLE=Marcus and Feldman’s Osteoporosis
Marcus and Feldman’s Osteoporosis, 1069-1082
STARTPAGE=1069;ENDPAGE=1082;TITLE=Marcus and Feldman’s Osteoporosis
Impaired bone health is a common complication of chronic inflammatory intestinal diseases, such as celiac disease and inflammatory bowel diseases, including Crohn’s disease and ulcerative colitis, already at diagnosis and during follow-up. Osteopen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::148005cfe763af6bcf422e2d658825a9
https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85126412859&origin=inward
https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85126412859&origin=inward
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Seinen, M L, de Boer, N K & van Bodegraven, A A 2019, ' Key insights from therapeutic drug monitoring in Crohn’s disease patients ', Expert Opinion on Drug Metabolism and Toxicology, vol. 15, no. 5, pp. 399-406 . https://doi.org/10.1080/17425255.2019.1597054
Expert Opinion on Drug Metabolism and Toxicology, 15(5), 399-406. Taylor and Francis Ltd.
Expert Opinion on Drug Metabolism and Toxicology, 15(5), 399-406. Taylor and Francis Ltd.
Introduction: The incidence and prevalence of Crohn’s disease are increasing causing a significant disease burden. Therapeutic drug monitoring (TDM) is advocated as a promising tool for personalized or individual-tailored therapy strategies and has
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c78ebde8a62a93e74c460398ec3b0feb
https://research.vumc.nl/en/publications/afc8711d-957f-4b18-8fc6-252a1b26252b
https://research.vumc.nl/en/publications/afc8711d-957f-4b18-8fc6-252a1b26252b
Autor:
Ad A. van Bodegraven, Ad A.M. Masclee, Daisy Jonkers, Bjorn Winkens, W. Hameeteman, Corinne E.G.M. Spooren, Marin J de Jong, Marie J. Pierik, Marco C. Becx, Andrea E. van der Meulen-de Jong, Tineke Markus, Mariëlle Romberg-Camps, Nofel Mahmmod, Jeroen Maljaars, Dion S J Wintjens
Publikováno v:
Digestive and Liver Disease, 51(9), 1265-1269
Digestive and Liver Disease, 51(9), 1265-1269. Elsevier Science
Digestive and Liver Disease, 51(9), 1265-1269. Elsevier Science
Background: Inflammatory bowel disease (IBD) patients are at risk of an impaired nutritional status. The impact thereof on the IBD relapse risk is clinically relevant, though sparsely investigated.Aim: The aim was to explore the association between a
Autor:
Anat Eck, C. M. F. Kneepkens, Carel F.W. Peeters, Andries E. Budding, T. G. J. de Meij, E. F. J. de Groot, N. K. H. de Boer, Ad A. van Bodegraven, Marc A. Benninga, Paul H. M. Savelkoul
Publikováno v:
PLoS ONE, 13(8). Public Library of Science
PLoS ONE, Vol 13, Iss 8, p e0197649 (2018)
PLOS ONE, 13(8):0197649. Public Library of Science
PLoS ONE, 13(8):e0197649. Public Library of Science
PLoS ONE
de Meij, T G J, de Groot, E F J, Peeters, C F W, de Boer, N K H, Kneepkens, C M F, Eck, A, Benninga, M A, Savelkoul, P H M, van Bodegraven, A A & Budding, A E 2018, ' Variability of core microbiota in newly diagnosed treatment-naïve paediatric inflammatory bowel disease patients ', PLoS ONE, vol. 13, no. 8, e0197649 . https://doi.org/10.1371/journal.pone.0197649
PLoS ONE, Vol 13, Iss 8, p e0197649 (2018)
PLOS ONE, 13(8):0197649. Public Library of Science
PLoS ONE, 13(8):e0197649. Public Library of Science
PLoS ONE
de Meij, T G J, de Groot, E F J, Peeters, C F W, de Boer, N K H, Kneepkens, C M F, Eck, A, Benninga, M A, Savelkoul, P H M, van Bodegraven, A A & Budding, A E 2018, ' Variability of core microbiota in newly diagnosed treatment-naïve paediatric inflammatory bowel disease patients ', PLoS ONE, vol. 13, no. 8, e0197649 . https://doi.org/10.1371/journal.pone.0197649
BACKGROUND & AIMSIntestinal microbiota is considered to play a crucial role in the aetiology of inflammatory bowel disease (IBD). We aimed to describe faecal microbiota composition and dynamics in a large cohort of children with de novo (naïve) IBD,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4c60708ed98365d57c2d971d8ddf4dc
Publikováno v:
Derijks, L J J, Wong, D R, Hommes, D W & van Bodegraven, A A 2018, ' Clinical Pharmacokinetic and Pharmacodynamic Considerations in the Treatment of Inflammatory Bowel Disease ', Clinical Pharmacokinetics, vol. 57, no. 9, pp. 1075-1106 . https://doi.org/10.1007/s40262-018-0639-4
According to recent clinical consensus, pharmacotherapy of inflammatory bowel disease (IBD) is, or should be, personalized medicine. IBD treatment is complex, with highly different treatment classes and relatively few data on treatment strategy. Alth